Drugs / Q10
last change Dec 2023 re-read 2 minutes ago

Q10

also known as coenzyme Q10 · CoQ10
Developed for
statin toxicity · NAFLD1
Investigated by
Oslo University Hospital · Pharma Nord

Trials 1 · a red edge is where a trial was stopped

20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT00113477 May 2005 → Dec 2007 statin toxicity Oslo University Hospital Completed No outcome recorded
Also used as a comparator or background therapy in 2 trials
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 21 trial
Phase 2 NCT05941910 Comparator Apr → Aug 2023 NAFLD1 Attikon Hospital Unknown No outcome recorded
Phase 41 trial
Phase 4 NCT02796378 Comparator Jun 2016 → Jul 2021 cardiovascular disorder, diabetes mellitus University of Copenhagen Unknown No outcome recorded

Evidence & citations 4 cited values

Every value below carries the sentence it was read from. 3 sources stand behind the page.

FieldValueCited text
Known as Q10 ClinicalTrials.gov intervention name — accepted as the source's own label NCT05941910
2

NCT00113477

NCT02796378

Known as coenzyme Q10 “effects of coenzyme Q10 (CoQ10) on endothelial, vascular and myocardial function in patients with NAFLD” NCT05941910
Known as CoQ10 “effects of coenzyme Q10 (CoQ10) on endothelial, vascular and myocardial function in patients with NAFLD” NCT05941910
Route Oral “400 mg of oral supplementation with Q10” NCT02796378